PMV Pharmaceuticals, Inc. (PMVP)
PMVPNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$1.29
+0.0700 (+5.74%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $94.39m
- P/E
- –
- EPS, last 4 quarters
- $-1.42
- Dividend yield
- –
- Day range
- –
- 52-week range
- $1.02 to $1.91
- Average volume
- 786.3k
- Previous close
- $1.22
Analysts
4 coveringBuy3 buy, 1 hold, 0 sell
Targets a year out average $4.00, +210.1% from here
Earnings
next estimate $-0.2800Next report Nov 11, 2026
Sep 2025
0.0%
Dec 2025
+15.0%
Mar 2026
+17.1%
Jun 2026
+10.5%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$22.52m | -$19.24m | -$19.02m | -$18.88m |
| Net income | -$21.06m | -$18.04m | -$18.04m | -$18.09m |
News
8 latest- Cardiff Names Alland Interim Medical Chief Ahead Of Planned Phase 3 Cancer Trial RTTNews · Oct 28, 2026
- PMVP Stock Rises 19% in 3 Months: Here's What You Need to KnowZacks · Oct 12, 2026
- Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP RTTNews · Oct 2, 2026
- Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross?Zacks · Sep 16, 2026
- PMV Pharma Names Herman Chief Commercial Officer Ahead Of Rezatapopt Filing RTTNews · Sep 9, 2026
- PMV Pharma Posts Interim Phase 2 PYNNACLE Ovarian Cancer Data; Prices $50.8 Mln Offering; Stock Down RTTNews · Sep 1, 2026
- PMV Pharmaceuticals (PMVP) Upgraded to Buy: What Does It Mean for the Stock?Zacks · Aug 19, 2026
- PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's WhyZacks · Jun 24, 2026
The company
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53. TP53 mutations are found in approximately half of all cancers. Our co-founder, Dr. Arnold Levine, established the field of p53 biology when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize more than four decades of p53 biology, PMV Pharma combines unique biological understanding with a pharmaceutical development focus. PMV Pharma is headquartered in Princeton, New Jersey. For more information, please visit www.pmvpharma.com.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- pmvpharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.